Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB

乙型肝炎表面抗原 医学 改良安卡拉痘苗 埃利斯波特 乙型肝炎病毒 病毒学 接种疫苗 牛痘 不利影响 乙型肝炎 CD8型 抗原 病毒 免疫学 内科学 生物 重组DNA 基因 生物化学
作者
Won Young Tak,Wan‐Long Chuang,Chi-Yi Chen,Kuo‐Chih Tseng,Young‐Suk Lim,Gin‐Ho Lo,Jeong Heo,Kaushik Agarwal,Louise Bussey,Sui Lynn Teoh,A. Tria,Anthony Brown,Katie J. Anderson,Antonella Vardeu,Susanne O’Brien,Jakub T. Kopycinski,Radka Kolenovska,Ellie Barnes,Thomas G. Evans
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:81 (6): 949-959 被引量:64
标识
DOI:10.1016/j.jhep.2024.06.027
摘要

Background and Aim The induction of effective CD8+ T cells is thought to play a critical role in the functional cure of chronic hepatitis B (CHB). Additionally, the use of checkpoint inhibitors is being evaluated to overcome T cell dysfunction during CHB. Approach and Results A chimpanzee adenoviral vector (ChAdOx1-HBV) and a Modified vaccinia Ankara boost (MVA-HBV) encoding the inactivated polymerase, core, and S region from a consensus genotype C HBV were studied. The trial enrolled 55 patients with virally-suppressed CHB virus infection and HBsAg <4,000 IU/mL Group 1 received MVA-HBV intramuscularly (IM) on Day 0 and 28, Group 2 received ChAdOx1-HBV on Day 0/MVA-HBV on Day 28 (VTP-300), Group 3 received VTP-300 + low-dose nivolumab (LDN) on Day 28, and Group 4 received VTP-300 plus LDN with both injections. VTP-300 alone and in combination with LDN was well tolerated with no treatment-related serious adverse events. Reductions of HBsAg were demonstrated in the VTP-300 group 2: 3 of 18 patients with starting HBsAg < 50 IU/ml had durable log10 declines > 0.7 log10 2 months post last-dose. Group 3 (N=18) had reductions in HBsAg of 0.76 log10 and 0.80 log10 3 (p<0.001) at 2 and 7 months post last dose. Two developed persistent non-detectable HBsAg levels. CD4+ and CD8+ antigen-specific T cell responses were generated and there was a correlation between IFN-y ELISpot response and HBsAg decline in Group 2. Conclusions VTP-300 induced CD4+ and CD8+ T cells and lowered HBsAg in a subset of patients with baseline values below 100 IU/ml. The addition of LDN resulted in significant reduction in surface antigen. VTP-300 is a promising immunotherapeutic to move forward alone or in combination therapies. Impact and implications The induction of potent, durable CD8+ T cells may be critical to achieving a functional cure in chronic hepatitis B virus infection. A prime-boost immunotherapeutic consisting of an adenoviral-vector encoding hepatitis B antigens followed by a pox virus boost was shown to induce CD8+ T cells and to lower HBsAg in CHB patients, either alone or more impactfully when administered in conjunction with a checkpoint inhibitor. The use of immunotherapeutics ClinTrials NCT047789
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坚定的可愁完成签到,获得积分10
2秒前
3秒前
liyuanyuan完成签到,获得积分10
3秒前
xhd183完成签到 ,获得积分10
4秒前
long-zhang发布了新的文献求助10
4秒前
赘婿的应助被xz采纳,获得10
5秒前
5秒前
彭于晏的应助被简单生活采纳,获得10
5秒前
Liy完成签到,获得积分10
5秒前
5秒前
6秒前
8秒前
可爱的函函的应助被xx采纳,获得10
8秒前
9秒前
10秒前
10秒前
深情安青的应助被Zhu采纳,获得10
11秒前
无私的青寒完成签到 ,获得积分10
11秒前
6366336发布了新的文献求助10
11秒前
13秒前
luxiaoyu发布了新的文献求助10
13秒前
kiwi发布了新的文献求助10
14秒前
倚栏听风完成签到 ,获得积分10
14秒前
15秒前
Ballas完成签到,获得积分10
15秒前
16秒前
16秒前
Seorina的应助被李一中采纳,获得10
17秒前
斯文败类的应助被荀万声采纳,获得10
17秒前
Wiki完成签到,获得积分10
17秒前
hu发布了新的文献求助10
17秒前
luoluoluoaaa123完成签到,获得积分10
19秒前
Horizon完成签到,获得积分10
19秒前
Qian发布了新的文献求助10
19秒前
xz发布了新的文献求助10
19秒前
溧谦发布了新的文献求助10
21秒前
赘婿的应助被kiwi采纳,获得10
22秒前
嘟嘟完成签到,获得积分10
23秒前
24秒前
草莓完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485